Delhi High Court slams Baba Ramdev for new video targeting Rooh Afza

The Delhi High Court on Thursday came down heavily on yoga guru Baba Ramdev for allegedly releasing a fresh video targeting Hamdard, despite an earlier undertaking to refrain from making similar statements against the brand.

The court was hearing a plea filed by Hamdard National Foundation India against Ramdev and his Patanjali Foods Ltd.

Last week, after the court slammed Ramdev over his remarks allegedly targeting Hamdard’s popular drink Rooh Afza as “Sharbat Jihad”, he agreed to immediately take down all related videos.

The court had then described Ramdev’s video as “indefensible” and “shocking” to the conscience of the court.

However, on Thursday, Hamdard’s counsel informed the court that Ramdev has posted yet another video containing objectionable content.

Senior advocate Sandeep Sethi, representing Hamdard, said, “Within a day, it has 8.9 lakh views and 8,500 likes and 2,200 comments and the video has gone viral. That is the reach of such a communal video which was far beyond what is permissible in law”.

Senior advocates Rajiv Nayar and Jayant Mehta, appearing for Ramdev and Patanjali, informed the court that, as per instructions, the offending portion of the latest video would be removed from all social media platforms within 24 hours. The counsel said there wasn’t disparagement of products of any other company in the video and that contempt was not attracted.

After watching the new video put out by Ramdev, Justice Amit Bansal told Ramdev’s counsel, “I think he (Ramdev) is beyond your control.” The counsel cannot justify such a video, the judge added.

“This shows the falsity of his affidavit in which he stated that he was a law-abiding citizen and strictly upholds the law of the land,” the court noted.

“He (Ramdev) is not in control of anyone. He lives in his own world,” the court remarked and posted the hearing in the case for Friday.

  • Related Posts

    Remedium Lifecare ‘s Breakthrough: A New Era in Pharma

    Mumbai: Remedium Lifecare Limited, a pivotal player in India’s pharmaceutical industry, has clinched a noteworthy contract with a UK-based pharmaceutical distribution firm, promising to amplify its stature in the global…

    An Index To Gauge States For Drug Enforcement, Improve Drug Quality

    New Delhi:  The Union government is drawing up an index to gauge states and union territories on their preparedness to enforce Central regulations on drugs, medical devices and cosmetics, according…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Piramal Pharma stock falls 5% after Q4 results; check key numbers here

    Piramal Pharma stock falls 5% after Q4 results; check key numbers here

    Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

    Biolumpivaxin: Bharat Biotech launches new vaccine against lumpy skin disease

    DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

    DTAB asks DCGI to take up withdrawal of license for certain FDC antibiotics with SLAs

    India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

    India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

    3 held with 60,000 tramadol tablets

    3 held with 60,000 tramadol tablets

    Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order

    Indian Pharma May See Limited Short-Term Impact from US Drug Pricing Order